Life Science Research and Develop

2025 will be an important year for the rapid development of life sciences in China

Today we will discuss the research and development of "life sciences" together. "Life science" is the science that studies the life phenomena and laws of life activities of organisms. It is not only the basis of biomedicine, but also the basis of life. From it, many biomedicine, biomedical engineering technology and other biotechnologies and disease diagnosis and treatment can be derived. Technical methods. Life science research and development have been a scientific research priority that has continued to develop globally for many years.

How do I understand life sciences?

Life science research studies the laws of life activities and the nature of life phenomena such as the origin, evolution, growth and development, and genetic variation of all life in nature, as well as the interconnections and relationships between various organisms and between organisms and the environment. The field of life science research is actually much broader than these four words, such as what is the biological basis of basic and clinical medicine, the biological basis of cognitive science, etc. Life science is not only about living life, but also directly related to our artificial intelligence calculations and even the artificial synthesis of new life forms.

At present, the field of biomedicine is developing rapidly and new technologies are emerging one after another. During the entire research process, there is a large demand for biological reagents, consumables and experimental instruments and equipment, which will promote related industries. At the same time, biology professionals have broad employment prospects, and there is a huge demand for scientific researchers and technical personnel in enterprises.

How will life sciences change in 2022?

The 2022 COVID-19 epidemic has affected the global economic operation and development. The generation, mutation, infection, pathogenic changes of the virus, and its effect on the human body are all based on life sciences and medicine, which can be used as a basis for us to adjust protection in a timely manner as the virus changes. The scientific and medical basis for the strategy. From this perspective, it also illustrates the strategic importance of life science research.

Combined with my own research field, today’s intelligent technology has become a very important technical field in our future. As my country increases its research on brain science, brain-inspired intelligence technology and artificial intelligence technology, it will greatly promote the development of diagnostic and treatment technologies for some brain diseases that have caused a great social burden in the long term.
At the same time, from the perspective of capital investment, according to incomplete statistics, global research capital investment in the field of life sciences in 2022 will reach 170 billion US dollars globally, with the United States accounting for nearly half and my country approximately 120 billion yuan, maintaining a growth trend.

In 2022, my country's biopharmaceutical industry will develop steadily. In 2022, the global life sciences and pharmaceutical sector M&A transactions will be extremely active, reaching US$410 billion. It was also a relatively active year for China's M&A market, which reached approximately US$25 billion, accounting for 6% of the world's total. Amgen's US$2.7 billion investment in BeiGene was the largest merger and acquisition in China's pharmaceutical and life sciences sectors.

How will life sciences impact 2025?

In 2025, life science research and development will continue to be a key area of scientific and technological development, and research and development results in related technical fields such as biomedicine, biomedical engineering, synthetic biotechnology, and intelligent technology will continue to appear and be transformed into implementation.

The development trend worthy of attention is the rapid and high-quality development of my country's life science industry. At present, the world's leading upstream companies in the life science industry are mainly concentrated in developed countries such as Europe, the United States and Japan. After years of accumulation, some Chinese companies have gradually formed core patents and become new market entrants that can compete with international leading companies. In 2025, China will be the It will be an important year for the development of biomedicine and biomedical engineering enterprises and will also be a key area for investment and financing.

• Next
  Biological reagent: key support for promoting life science research